Bioxytran's total assets for Q2 2026 were $333.39K, a decrease of -45.81% from the previous quarter. BIXT total liabilities were $5.27M for the fiscal quarter, a 5.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.